Giant Cell Arteritis (GCA)

If you are interested in learning more about a study, email our research group at rheumatologyresearch@uphs.upenn.edu.

Study Name

Drug Study

Disease Studied

Currently Enrolling

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) YES GPA, MPA, EGPA, GCA, TAK, PAN YES
VCRC Genetic Repository One-Time DNA Study NO GPA, MPA, EGPA, GCA, TAK, PAN YES
Researching Micro-Organisms in Large-Vessel Vasculitis (RESOLVE) NO GCA & TAK NO
Vessel Wall Enhancement in Giant Cell Arteritis (VEGA) NO GCA YES
Tissue Repository Collection Protocol NO GPA, MPA, EGPA, GCA, TAK, PAN, cutaneous vasculitis YES
SELECT-GCA: Upadacitinib in Giant Cell Arteritis YES GCA NO

Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)

YES GCA YES